- Home
- PKBK vs OABI Comparison
PKBK vs OABI Comparison
Compare PKBK & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKBK
- OABI
- Stock Information
- Founded
- PKBK 1999
- OABI 2012
- Country
- PKBK United States
- OABI United States
- Employees
- PKBK N/A
- OABI N/A
- Industry
- PKBK Major Banks
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- PKBK Finance
- OABI Health Care
- Exchange
- PKBK Nasdaq
- OABI Nasdaq
- Market Cap
- PKBK 269.2M
- OABI 228.9M
- IPO Year
- PKBK N/A
- OABI N/A
- Fundamental
- Price
- PKBK $22.55
- OABI $1.63
- Analyst Decision
- PKBK
- OABI Strong Buy
- Analyst Count
- PKBK 0
- OABI 3
- Target Price
- PKBK N/A
- OABI $6.67
- AVG Volume (30 Days)
- PKBK 33.9K
- OABI 402.3K
- Earning Date
- PKBK 10-17-2025
- OABI 11-11-2025
- Dividend Yield
- PKBK 3.19%
- OABI N/A
- EPS Growth
- PKBK 42.58
- OABI N/A
- EPS
- PKBK 2.56
- OABI N/A
- Revenue
- PKBK $66,879,999.00
- OABI $23,027,000.00
- Revenue This Year
- PKBK N/A
- OABI N/A
- Revenue Next Year
- PKBK N/A
- OABI $44.99
- P/E Ratio
- PKBK $8.80
- OABI N/A
- Revenue Growth
- PKBK 3.52
- OABI 6.05
- 52 Week Low
- PKBK $16.94
- OABI $1.22
- 52 Week High
- PKBK $24.29
- OABI $4.87
- Technical
- Relative Strength Index (RSI)
- PKBK 59.21
- OABI 42.41
- Support Level
- PKBK $22.27
- OABI $1.55
- Resistance Level
- PKBK $22.85
- OABI $1.73
- Average True Range (ATR)
- PKBK 0.36
- OABI 0.10
- MACD
- PKBK -0.01
- OABI 0.00
- Stochastic Oscillator
- PKBK 62.38
- OABI 25.88
About PKBK Parke Bancorp Inc.
Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending among others. The Company operates one reportable segment of business, community banking.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.